Treatment-related mortality due to infectious complications following poten
tially curable aggressive chemotherapy remains a major clinical problem. Ho
wever, the diagnosis of neutropenic infections is difficult. Although it is
common practice to institute empirical broad-spectrum antibiotics in neutr
openic fever, liberal use of antibiotics may contribute to increasing resis
tance and superinfection such as systemic mycosis. Clinicians are searching
for a highly specific and sensitive marker indicating early infection. Ser
um concentrations of several acute-phase proteins (C-reactive protein, seru
m amyloid A), proinflammatory cytokines (TNF alpha, IL-1, IFN gamma, IL-6,
IL-8), soluble adhesion molecules (soluble E-selectin, vascular cell adhesi
on molecule 1, intercellular adhesion molecule 1) and more recently procalc
itonin have been investigated as to whether these may contribute to identif
ying infections as the cause of neutropenic fever. Unfortunately, at presen
t, based on the small and inconsistent amount of data available from the li
terature one is tempted to conclude that the predictive values of all these
parameters are too low to influence the clinically based initial treatment
decisions in patients with neutropenic fever. Copyright (C) 2000 S. Karger
AG, Basel.